Published 
April 29th, 2024 – MSD (Thailand) Ltd. (a wholly owned subsidiary of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), and the Faculty of Medicine Siriraj Hospital, Mahidol University, announced the signing of an agreement for the establishment of the Clinical Site Partnership Project in Thailand. The partnership aims to enhance cooperation in the research and development (R&D) of innovative medicine and vaccines and improve clinical research standards to drive innovation around disease prevention and treatment in line with emerging diseases.
For more details, please read at https://bit.ly/4aqql1p
